Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: A randomised, controlled intervention study

Lancet

Volumn 355, Issue 9205, 2000, Pages 701-706

  Crawley, Jane ^a   Waruiru, Catherine ^a   Mithwani, Sadik ^a   Mwangi, Isiah ^a   Watkins, William ^c,d   Ouma, David ^c   Winstanley, Peter ^d   Peto, Timothy ^b   Marsh, Kevin ^e  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CHLORAMPHENICOL; DIAZEPAM; PENICILLIN G; PHENOBARBITAL; PHENYTOIN; QUININE;

ADOLESCENT; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFANT; KENYA; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; RESPIRATORY ARREST; SEIZURE;

EID: 0034716492     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)07148-2     Document Type: Article

References (33)

1. World malaria situation in 1994. Wkly Epidemiol Rec. 72:1997;269-290.
2. Jaffar S., Van Hensbroek M.B., Palmer A., Schneider G., Greenwood B. Predictors of a fatal outcome following childhood cerebral malaria. Am J Trop Med Hyg. 57:1997;20-24.
3. Molyneux M.E., Taylor T.E., Wirima J.J., Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. QJM. 71:1989;441-459.
4. Brewster D.R., Kwiatkowski D., White N.J. Neurological sequelae of cerebral malaria in children. Lancet. 336:1990;1039-1043.
5. Crawley J., Smith S., Kirkham F., Muthinji P., Waruiru C., Marsh K. Seizures and status epilepticus in childhood cerebral malaria. QJM. 89:1996;591-597.
6. Shorvon S. Status epilepticus: its clinical features and treatment in children and adults. 1994;Cambridge University Press, Cambridge.
7. Rylance G.W. Treatment of epilepsy and febrile convulsions in children. Lancet. 336:1990;488-491.
8. Bone R.C. Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America's working group on status epilepticus. JAMA. 270:1993;854-859.
9. White N.J., Phillips R.E., Looareesuwan S., Chanthavanich P., Warrell D.A. Single-dose phenobarbitone prevents convulsions in cerebral malaria. Lancet. ii:1988;64-66.
10. Winstanley P.A., Newton C.R.J.C., Pasvol G.et al. Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects. Br J Clin Pharmacol. 33:1992;149-154.
11. Faero O., Kastrup K.W., Nielsen E.L., Melchior J.C., Thorn I. Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia. 13:1979;279-285.
12. Pearce J.L., Sharman J.R., Forster R.M. Phenobarbital in the acute management of febrile convulsions. Pediatrics. 60:1977;569-572.
13. Snow R.W., Armstrong-Schellenberg J.R.M., Peshu N.et al. Periodicity and space-time clustering of severe childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg. 87:1993;386-390.
14. Newton C.R.J.C., Crawley J., Sowumni A.et al. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child. 76:1997;219-226.
15. Winstanley P.A., Mberu E.K., Watkins W.M., Murphy S.A., Lowe B., Marsh K. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg. 88:1994;577-580.
16. Crawley J. Malaria; new challenges, new treatments. Curr Paediatr. 9:1999;34-41.
17. Peto R., Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc. 135:1972;185-207.
18. Dodson W.E. Antiepileptic drug utilization in pediatric patients. Epilepsia. 25:1984;132-139.
19. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Arch Neurol. 29:1973;82-87.
20. Stafstrom C.E., Chronopoulos A., Thurber S., Thompson J.L., Holmes G.L. Age-dependent cognitive and behavioral deficits after kainic acid seizures. Epilepsia. 34:1993;420-432.
21. Sutula T., Cavazos J., Golarai G. Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital. J Neurosci. 12:1992;4173-4187.
22. Mikati M.A., Holmes G.L., Chronopoulos A.et al. Phenobarbital modifies seizure-related brain injury in the developing brain. Ann Neurol. 36:1994;425-433.
23. Shaner M.D., McCurdy S.A., Herring M.O., Gabor A.J. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and and optional phenytoin. Neurology. 38:1988;202-207.
24. Treiman D.M., Meyers P.D., Walton N.Y.et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 339:1998;792-798.
25. Crawford T.O., Mitchell W.G., Fishman L.S., Snodgrass S.R. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology. 38:1988;1035-1040.
26. Prensky A.L., Raff M.C., Moore M.J., Schwab R.S. Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med. 276:1967;779-784.
27. Sawyer G.T., Webster D.D., Schut L.J. Treatment of uncontrolled seizure activity with diazepam. JAMA. 203:1968;111-116.
28. Treiman D.M., Gunawan S., Walton N.Y., Meyers P.D. Serum concentrations of antiepileptic drugs following intravenous administration for the treatment of status epilepticus. Epilepsia. 33:1992;3-4. (suppl 3).
29. Simon R.P., Copeland J.R., Benowitz N.L., Jacob P., Bronstein J. Brain phenobarbital uptake during prolonged status epilepticus. J Cereb Blood Flow Metab. 7:1987;783-788.
30. Ramsay R.E., Hammond E.J., Perchalski R.J., Wilder B.J. Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol. 36:1979;535-539.
31. Brzakovic B., Pokrajac M., Dzoljic E., Levic Z., Varagic V.M. Cerebrospinal fluid and plasma pharmacokinetics of phenobarbital after intravenous administration to patients with status epilepticus. Clin Drug Invest. 14:1997;307-313.
32. Goldberg M.A., MacIntyre H.B. Barbiturates in the treatment of status epilepticus. Delgado-Escueta A.V., Wasterlain C.G., Treiman D.M., Porter R.J. Advances in neurology. 1983;499-503 Raven Press, New York.
33. Duley L. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 345:1995;1455-1463.